Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced that its Board of Directors has declared a quarterly cash dividend of $0.86 per share.
The dividend is payable on October 21, 2026, to shareholders of record of Quest Diagnostics common stock as of October 6, 2026.
Positive
- Quarterly dividend declared at $0.86 per share, payable October 21, 2026
- Shareholder record date set for October 6, 2026, clarifying eligibility
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302849946.html
SOURCE Quest Diagnostics